跳至主要内容
临床试验/ChiCTR1800015151
ChiCTR1800015151已完成Unknown

行為激活加靜觀對抑鬱的療效研究

未提供1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 1990年1月1日最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
158
试验地点
1
主要终点
Patient Health Questionnaire (PHQ-9)

研究概览

简要总结

行為激活加靜觀對抑鬱的療效研究

研究设计

研究类型
Interventional
主要目的
随机平行对照
盲法
Single

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • Aged 18 years or above;
  • Screened by the Patient Health Questionnaire (PHQ-9) with a score of 10 or above;
  • Screened positive for major depression using the Structured Clinical Interview for DSM-V (SCID).

排除标准

  • Having a lifetime history of psychosis, schizophrenia and bipolar affective disorder, alcohol or substance abuse, the presence of serious suicidal risk or medical illness with a prognosis of less than 6 months to live;
  • Currently receiving any psychotherapy including being enrolled in the integrated mental health program (IMHP) or was enrolled in the IMHP within the past 6 months;
  • Having received any psychotherapy in the past 6 months; and
  • currently practising or has practiced meditation or enrolled in mindfulness based interventions during the past one year.

研究组 & 干预措施

Two groups

psychoeducation with respect to well-being, setting both short and long-term goals, self-monitoring of activity and mood using activity logs to recognize the association between specific activities and mood, scheduling daily activities, and identification of avoidance and its impact versus receive their usual mental health

结局指标

主要结局

Patient Health Questionnaire (PHQ-9)

时间窗: At 6 months (T2) post-randomisation

次要结局

  • Patient Health Questionnaire (PHQ-9)(At 2 months (T1) and 12 months (T3) post randomisation.)
  • The Structured Clinical Interview for DSM-IV (SCID)(Assessed at baseline (T0), and 2 (T1), 6 (T2), and 12 months (T3) post randomisation.)
  • Generalized Anxiety Disorder 7 item scale (GAD-7)(Assessed at baseline (T0), and 2 (T1), 6 (T2), and 12 months (T3) post randomisation.)
  • Quality-adjusted life-year (QALY)(Assessed at baseline (T0), and 2 (T1), 6 (T2), and 12 months (T3) post randomisation.)
  • Cost effectiveness analysis(Assessed at baseline (T0), and 2 (T1), 6 (T2), and 12 months (T3) post randomisation.)
  • Activity and Circumstantial Change(Assessed at baseline (T0), and 2 (T1), 6 (T2), and 12 months (T3) post randomisation.)
  • Health service utilization and medication use(Assessed at baseline (T0), and 2 (T1), 6 (T2), and 12 months (T3) post randomisation.)

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验